 | • レポートコード：B-GIR08C1198 • 出版社/出版日：GlobalInfoResearch / 2019年7月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、118ページ • 納品方法：Eメール • 産業分類：Medical Care |
| Single User | ￥522,000 (USD3,480) | ▷ お問い合わせ |
| Corporate User | ￥1,044,000 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートは、化学療法誘発性好中球減少症治療の世界市場について調べ、まとめました。種類別セグメントは、抗生物質療法、コロニー刺激因子療法、顆粒球輸血、脾臓摘出術、その他等、用途別セグメントは、等に区分しました。化学療法誘発性好中球減少症治療の世界市場概観、企業動向、企業別化学療法誘発性好中球減少症治療シェア、市場規模推移、市場規模予測（2019年-2024年）、主要地域分析（北米、ヨーロッパ、アジア等）、主要国分析（日本、中国、アメリカ等）データなどの情報が含まれています。 ・化学療法誘発性好中球減少症治療の市場概観 ・化学療法誘発性好中球減少症治療の企業概要（事業概要、製品種類、販売量、価格、売上、市場シェア等） ・化学療法誘発性好中球減少症治療の企業別販売動向、市場シェア、市場集中度、競争動向 ・化学療法誘発性好中球減少症治療の世界市場規模 ・化学療法誘発性好中球減少症治療の北米市場分析（アメリカ、カナダ、メキシコ等） ・化学療法誘発性好中球減少症治療のアメリカ市場規模推移 ・化学療法誘発性好中球減少症治療のカナダ市場規模推移 ・化学療法誘発性好中球減少症治療のメキシコ市場規模推移 ・化学療法誘発性好中球減少症治療のヨーロッパ市場分析（ドイツ、イギリス、ロシア、フランス、イタリア等） ・化学療法誘発性好中球減少症治療のドイツ市場規模推移 ・化学療法誘発性好中球減少症治療のイギリス市場規模推移 ・化学療法誘発性好中球減少症治療のロシア市場規模推移 ・化学療法誘発性好中球減少症治療のアジア太平洋市場分析（日本、中国、韓国、インド、東南アジア等） ・化学療法誘発性好中球減少症治療の日本市場規模推移 ・化学療法誘発性好中球減少症治療の中国市場規模推移 ・化学療法誘発性好中球減少症治療の韓国市場規模推移 ・化学療法誘発性好中球減少症治療のインド市場規模推移 ・化学療法誘発性好中球減少症治療の東南アジア市場規模推移 ・化学療法誘発性好中球減少症治療の南米市場分析（ブラジル、アルゼンチン等） ・化学療法誘発性好中球減少症治療の中東・アフリカ市場分析（サウジアラビア、UAE、南アフリカ等） ・化学療法誘発性好中球減少症治療の種類別分析/販売量、売上、市場シェア（抗生物質療法、コロニー刺激因子療法、顆粒球輸血、脾臓摘出術、その他） ・化学療法誘発性好中球減少症治療の用途別分析/市場規模（） ・化学療法誘発性好中球減少症治療の市場予測2019年-2024年（地域別予測、種類別予測、用途別予測） ・化学療法誘発性好中球減少症治療の販売チャネル・代理店・貿易業者・ディーラー分析 |
Scope of the Report:
The global Chemotherapy-Induced Neutropenia Treatment market is valued at million USD in 2018 and is expected to reach million USD by the end of 2024, growing at a CAGR of between 2019 and 2024.
The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.
North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Chemotherapy-Induced Neutropenia Treatment.
Europe also play important roles in global market, with market size of xx million USD in 2019 and will be xx million USD in 2024, with a CAGR of xx%.
This report studies the Chemotherapy-Induced Neutropenia Treatment market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Chemotherapy-Induced Neutropenia Treatment market by product type and applications/end industries.
Market Segment by Companies, this report covers
Amgen
Sanofi
Novartis AG
Baxter International
Teva Pharmaceuticals Industries
Apotex
Dr. Reddy’s Laboratory
Biogenomics Limited
Ligand Pharmaceuticals
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Antibiotic Therapy
Colony-Stimulating Factor Therapy
Granulocyte Transfusion
Splenectomy Procedure
Others
Market Segment by Applications, can be divided into
Hospital Pharmacy
Retail Pharmacy
Online Pharmacy
Table of Contents
1 Chemotherapy-Induced Neutropenia Treatment Market Overview
1.1 Product Overview and Scope of Chemotherapy-Induced Neutropenia Treatment
1.2 Classification of Chemotherapy-Induced Neutropenia Treatment by Types
1.2.1 Global Chemotherapy-Induced Neutropenia Treatment Revenue Comparison by Types (2019-2024)
1.2.2 Global Chemotherapy-Induced Neutropenia Treatment Revenue Market Share by Types in 2018
1.2.3 Antibiotic Therapy
1.2.4 Colony-Stimulating Factor Therapy
1.2.5 Granulocyte Transfusion
1.2.6 Splenectomy Procedure
1.2.7 Others
1.3 Global Chemotherapy-Induced Neutropenia Treatment Market by Application
1.3.1 Global Chemotherapy-Induced Neutropenia Treatment Market Size and Market Share Comparison by Applications (2014-2024)
1.3.2 Hospital Pharmacy
1.3.3 Retail Pharmacy
1.3.4 Online Pharmacy
1.4 Global Chemotherapy-Induced Neutropenia Treatment Market by Regions
1.4.1 Global Chemotherapy-Induced Neutropenia Treatment Market Size (Million USD) Comparison by Regions (2014-2024)
1.4.1 North America (USA, Canada and Mexico) Chemotherapy-Induced Neutropenia Treatment Status and Prospect (2014-2024)
1.4.2 Europe (Germany, France, UK, Russia and Italy) Chemotherapy-Induced Neutropenia Treatment Status and Prospect (2014-2024)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Chemotherapy-Induced Neutropenia Treatment Status and Prospect (2014-2024)
1.4.4 South America (Brazil, Argentina, Colombia) Chemotherapy-Induced Neutropenia Treatment Status and Prospect (2014-2024)
1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Chemotherapy-Induced Neutropenia Treatment Status and Prospect (2014-2024)
1.5 Global Market Size of Chemotherapy-Induced Neutropenia Treatment (2014-2024)
2 Manufacturers Profiles
2.1 Amgen
2.1.1 Business Overview
2.1.2 Chemotherapy-Induced Neutropenia Treatment Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Amgen Chemotherapy-Induced Neutropenia Treatment Revenue, Gross Margin and Market Share (2017-2018)
2.2 Sanofi
2.2.1 Business Overview
2.2.2 Chemotherapy-Induced Neutropenia Treatment Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Sanofi Chemotherapy-Induced Neutropenia Treatment Revenue, Gross Margin and Market Share (2017-2018)
2.3 Novartis AG
2.3.1 Business Overview
2.3.2 Chemotherapy-Induced Neutropenia Treatment Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Novartis AG Chemotherapy-Induced Neutropenia Treatment Revenue, Gross Margin and Market Share (2017-2018)
2.4 Baxter International
2.4.1 Business Overview
2.4.2 Chemotherapy-Induced Neutropenia Treatment Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Baxter International Chemotherapy-Induced Neutropenia Treatment Revenue, Gross Margin and Market Share (2017-2018)
2.5 Teva Pharmaceuticals Industries
2.5.1 Business Overview
2.5.2 Chemotherapy-Induced Neutropenia Treatment Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Teva Pharmaceuticals Industries Chemotherapy-Induced Neutropenia Treatment Revenue, Gross Margin and Market Share (2017-2018)
2.6 Apotex
2.6.1 Business Overview
2.6.2 Chemotherapy-Induced Neutropenia Treatment Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Apotex Chemotherapy-Induced Neutropenia Treatment Revenue, Gross Margin and Market Share (2017-2018)
2.7 Dr. Reddy’s Laboratory
2.7.1 Business Overview
2.7.2 Chemotherapy-Induced Neutropenia Treatment Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 Dr. Reddy’s Laboratory Chemotherapy-Induced Neutropenia Treatment Revenue, Gross Margin and Market Share (2017-2018)
2.8 Biogenomics Limited
2.8.1 Business Overview
2.8.2 Chemotherapy-Induced Neutropenia Treatment Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 Biogenomics Limited Chemotherapy-Induced Neutropenia Treatment Revenue, Gross Margin and Market Share (2017-2018)
2.9 Ligand Pharmaceuticals
2.9.1 Business Overview
2.9.2 Chemotherapy-Induced Neutropenia Treatment Type and Applications
2.9.2.1 Product A
2.9.2.2 Product B
2.9.3 Ligand Pharmaceuticals Chemotherapy-Induced Neutropenia Treatment Revenue, Gross Margin and Market Share (2017-2018)
3 Global Chemotherapy-Induced Neutropenia Treatment Market Competition, by Players
3.1 Global Chemotherapy-Induced Neutropenia Treatment Revenue and Share by Players (2014-2019)
3.2 Market Concentration Rate
3.2.1 Top 5 Chemotherapy-Induced Neutropenia Treatment Players Market Share
3.2.2 Top 10 Chemotherapy-Induced Neutropenia Treatment Players Market Share
3.3 Market Competition Trend
4 Global Chemotherapy-Induced Neutropenia Treatment Market Size by Regions
4.1 Global Chemotherapy-Induced Neutropenia Treatment Revenue and Market Share by Regions
4.2 North America Chemotherapy-Induced Neutropenia Treatment Revenue and Growth Rate (2014-2019)
4.3 Europe Chemotherapy-Induced Neutropenia Treatment Revenue and Growth Rate (2014-2019)
4.4 Asia-Pacific Chemotherapy-Induced Neutropenia Treatment Revenue and Growth Rate (2014-2019)
4.5 South America Chemotherapy-Induced Neutropenia Treatment Revenue and Growth Rate (2014-2019)
4.6 Middle East and Africa Chemotherapy-Induced Neutropenia Treatment Revenue and Growth Rate (2014-2019)
5 North America Chemotherapy-Induced Neutropenia Treatment Revenue by Countries
5.1 North America Chemotherapy-Induced Neutropenia Treatment Revenue by Countries (2014-2019)
5.2 USA Chemotherapy-Induced Neutropenia Treatment Revenue and Growth Rate (2014-2019)
5.3 Canada Chemotherapy-Induced Neutropenia Treatment Revenue and Growth Rate (2014-2019)
5.4 Mexico Chemotherapy-Induced Neutropenia Treatment Revenue and Growth Rate (2014-2019)
6 Europe Chemotherapy-Induced Neutropenia Treatment Revenue by Countries
6.1 Europe Chemotherapy-Induced Neutropenia Treatment Revenue by Countries (2014-2019)
6.2 Germany Chemotherapy-Induced Neutropenia Treatment Revenue and Growth Rate (2014-2019)
6.3 UK Chemotherapy-Induced Neutropenia Treatment Revenue and Growth Rate (2014-2019)
6.4 France Chemotherapy-Induced Neutropenia Treatment Revenue and Growth Rate (2014-2019)
6.5 Russia Chemotherapy-Induced Neutropenia Treatment Revenue and Growth Rate (2014-2019)
6.6 Italy Chemotherapy-Induced Neutropenia Treatment Revenue and Growth Rate (2014-2019)
7 Asia-Pacific Chemotherapy-Induced Neutropenia Treatment Revenue by Countries
7.1 Asia-Pacific Chemotherapy-Induced Neutropenia Treatment Revenue by Countries (2014-2019)
7.2 China Chemotherapy-Induced Neutropenia Treatment Revenue and Growth Rate (2014-2019)
7.3 Japan Chemotherapy-Induced Neutropenia Treatment Revenue and Growth Rate (2014-2019)
7.4 Korea Chemotherapy-Induced Neutropenia Treatment Revenue and Growth Rate (2014-2019)
7.5 India Chemotherapy-Induced Neutropenia Treatment Revenue and Growth Rate (2014-2019)
7.6 Southeast Asia Chemotherapy-Induced Neutropenia Treatment Revenue and Growth Rate (2014-2019)
8 South America Chemotherapy-Induced Neutropenia Treatment Revenue by Countries
8.1 South America Chemotherapy-Induced Neutropenia Treatment Revenue by Countries (2014-2019)
8.2 Brazil Chemotherapy-Induced Neutropenia Treatment Revenue and Growth Rate (2014-2019)
8.3 Argentina Chemotherapy-Induced Neutropenia Treatment Revenue and Growth Rate (2014-2019)
8.4 Colombia Chemotherapy-Induced Neutropenia Treatment Revenue and Growth Rate (2014-2019)
9 Middle East and Africa Revenue Chemotherapy-Induced Neutropenia Treatment by Countries
9.1 Middle East and Africa Chemotherapy-Induced Neutropenia Treatment Revenue by Countries (2014-2019)
9.2 Saudi Arabia Chemotherapy-Induced Neutropenia Treatment Revenue and Growth Rate (2014-2019)
9.3 UAE Chemotherapy-Induced Neutropenia Treatment Revenue and Growth Rate (2014-2019)
9.4 Egypt Chemotherapy-Induced Neutropenia Treatment Revenue and Growth Rate (2014-2019)
9.5 Nigeria Chemotherapy-Induced Neutropenia Treatment Revenue and Growth Rate (2014-2019)
9.6 South Africa Chemotherapy-Induced Neutropenia Treatment Revenue and Growth Rate (2014-2019)
10 Global Chemotherapy-Induced Neutropenia Treatment Market Segment by Type
10.1 Global Chemotherapy-Induced Neutropenia Treatment Revenue and Market Share by Type (2014-2019)
10.2 Global Chemotherapy-Induced Neutropenia Treatment Market Forecast by Type (2019-2024)
10.3 Antibiotic Therapy Revenue Growth Rate (2014-2024)
10.4 Colony-Stimulating Factor Therapy Revenue Growth Rate (2014-2024)
10.5 Granulocyte Transfusion Revenue Growth Rate (2014-2024)
10.6 Splenectomy Procedure Revenue Growth Rate (2014-2024)
10.7 Others Revenue Growth Rate (2014-2024)
11 Global Chemotherapy-Induced Neutropenia Treatment Market Segment by Application
11.1 Global Chemotherapy-Induced Neutropenia Treatment Revenue Market Share by Application (2014-2019)
11.2 Chemotherapy-Induced Neutropenia Treatment Market Forecast by Application (2019-2024)
11.3 Hospital Pharmacy Revenue Growth (2014-2019)
11.4 Retail Pharmacy Revenue Growth (2014-2019)
11.5 Online Pharmacy Revenue Growth (2014-2019)
12 Global Chemotherapy-Induced Neutropenia Treatment Market Size Forecast (2019-2024)
12.1 Global Chemotherapy-Induced Neutropenia Treatment Market Size Forecast (2019-2024)
12.2 Global Chemotherapy-Induced Neutropenia Treatment Market Forecast by Regions (2019-2024)
12.3 North America Chemotherapy-Induced Neutropenia Treatment Revenue Market Forecast (2019-2024)
12.4 Europe Chemotherapy-Induced Neutropenia Treatment Revenue Market Forecast (2019-2024)
12.5 Asia-Pacific Chemotherapy-Induced Neutropenia Treatment Revenue Market Forecast (2019-2024)
12.6 South America Chemotherapy-Induced Neutropenia Treatment Revenue Market Forecast (2019-2024)
12.7 Middle East and Africa Chemotherapy-Induced Neutropenia Treatment Revenue Market Forecast (2019-2024)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
Figure Chemotherapy-Induced Neutropenia Treatment Picture
Table Product Specifications of Chemotherapy-Induced Neutropenia Treatment
Table Global Chemotherapy-Induced Neutropenia Treatment and Revenue (Million USD) Market Split by Product Type
Figure Global Chemotherapy-Induced Neutropenia Treatment Revenue Market Share by Types in 2018
Figure Antibiotic Therapy Picture
Figure Colony-Stimulating Factor Therapy Picture
Figure Granulocyte Transfusion Picture
Figure Splenectomy Procedure Picture
Figure Others Picture
Table Global Chemotherapy-Induced Neutropenia Treatment Revenue (Million USD) by Application (2014-2024)
Figure Chemotherapy-Induced Neutropenia Treatment Revenue Market Share by Applications in 2018
Figure Hospital Pharmacy Picture
Figure Retail Pharmacy Picture
Figure Online Pharmacy Picture
Table Global Market Chemotherapy-Induced Neutropenia Treatment Revenue (Million USD) Comparison by Regions 2014-2024
Figure North America Chemotherapy-Induced Neutropenia Treatment Revenue (Million USD) and Growth Rate (2014-2024)
Figure Europe Chemotherapy-Induced Neutropenia Treatment Revenue (Million USD) and Growth Rate (2014-2024)
Figure Asia-Pacific Chemotherapy-Induced Neutropenia Treatment Revenue (Million USD) and Growth Rate (2014-2024)
Figure South America Chemotherapy-Induced Neutropenia Treatment Revenue (Million USD) and Growth Rate (2014-2024)
Figure Middle East and Africa Chemotherapy-Induced Neutropenia Treatment Revenue (Million USD) and Growth Rate (2014-2024)
Figure Global Chemotherapy-Induced Neutropenia Treatment Revenue (Million USD) and Growth Rate (2014-2024)
Table Amgen Basic Information, Manufacturing Base and Competitors
Table Amgen Chemotherapy-Induced Neutropenia Treatment Type and Applications
Table Amgen Chemotherapy-Induced Neutropenia Treatment Revenue, Gross Margin and Market Share (2017-2018)
Table Sanofi Basic Information, Manufacturing Base and Competitors
Table Sanofi Chemotherapy-Induced Neutropenia Treatment Type and Applications
Table Sanofi Chemotherapy-Induced Neutropenia Treatment Revenue, Gross Margin and Market Share (2017-2018)
Table Novartis AG Basic Information, Manufacturing Base and Competitors
Table Novartis AG Chemotherapy-Induced Neutropenia Treatment Type and Applications
Table Novartis AG Chemotherapy-Induced Neutropenia Treatment Revenue, Gross Margin and Market Share (2017-2018)
Table Baxter International Basic Information, Manufacturing Base and Competitors
Table Baxter International Chemotherapy-Induced Neutropenia Treatment Type and Applications
Table Baxter International Chemotherapy-Induced Neutropenia Treatment Revenue, Gross Margin and Market Share (2017-2018)
Table Teva Pharmaceuticals Industries Basic Information, Manufacturing Base and Competitors
Table Teva Pharmaceuticals Industries Chemotherapy-Induced Neutropenia Treatment Type and Applications
Table Teva Pharmaceuticals Industries Chemotherapy-Induced Neutropenia Treatment Revenue, Gross Margin and Market Share (2017-2018)
Table Apotex Basic Information, Manufacturing Base and Competitors
Table Apotex Chemotherapy-Induced Neutropenia Treatment Type and Applications
Table Apotex Chemotherapy-Induced Neutropenia Treatment Revenue, Gross Margin and Market Share (2017-2018)
Table Dr. Reddy’s Laboratory Basic Information, Manufacturing Base and Competitors
Table Dr. Reddy’s Laboratory Chemotherapy-Induced Neutropenia Treatment Type and Applications
Table Dr. Reddy’s Laboratory Chemotherapy-Induced Neutropenia Treatment Revenue, Gross Margin and Market Share (2017-2018)
Table Biogenomics Limited Basic Information, Manufacturing Base and Competitors
Table Biogenomics Limited Chemotherapy-Induced Neutropenia Treatment Type and Applications
Table Biogenomics Limited Chemotherapy-Induced Neutropenia Treatment Revenue, Gross Margin and Market Share (2017-2018)
Table Ligand Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table Ligand Pharmaceuticals Chemotherapy-Induced Neutropenia Treatment Type and Applications
Table Ligand Pharmaceuticals Chemotherapy-Induced Neutropenia Treatment Revenue, Gross Margin and Market Share (2017-2018)
Table Global Chemotherapy-Induced Neutropenia Treatment Revenue (Million USD) by Players (2014-2019)
Table Global Chemotherapy-Induced Neutropenia Treatment Revenue Share by Players (2014-2019)
Figure Global Chemotherapy-Induced Neutropenia Treatment Revenue Share by Players in 2017
Figure Global Chemotherapy-Induced Neutropenia Treatment Revenue Share by Players in 2018
Figure Global Top 5 Players Chemotherapy-Induced Neutropenia Treatment Revenue Market Share in 2018
Figure Global Top 10 Players Chemotherapy-Induced Neutropenia Treatment Revenue Market Share in 2018
Figure Global Chemotherapy-Induced Neutropenia Treatment Revenue (Million USD) and Growth Rate (%) (2014-2019)
Table Global Chemotherapy-Induced Neutropenia Treatment Revenue (Million USD) by Regions (2014-2019)
Table Global Chemotherapy-Induced Neutropenia Treatment Revenue Market Share by Regions (2014-2019)
Figure Global Chemotherapy-Induced Neutropenia Treatment Revenue Market Share by Regions (2014-2019)
Figure Global Chemotherapy-Induced Neutropenia Treatment Revenue Market Share by Regions in 2018
Figure North America Chemotherapy-Induced Neutropenia Treatment Revenue and Growth Rate (2014-2019)
Figure Europe Chemotherapy-Induced Neutropenia Treatment Revenue and Growth Rate (2014-2019)
Figure Asia-Pacific Chemotherapy-Induced Neutropenia Treatment Revenue and Growth Rate (2014-2019)
Figure South America Chemotherapy-Induced Neutropenia Treatment Revenue and Growth Rate (2014-2019)
Figure Middle East and Africa Chemotherapy-Induced Neutropenia Treatment Revenue and Growth Rate (2014-2019)
Table North America Chemotherapy-Induced Neutropenia Treatment Revenue by Countries (2014-2019)
Table North America Chemotherapy-Induced Neutropenia Treatment Revenue Market Share by Countries (2014-2019)
Figure North America Chemotherapy-Induced Neutropenia Treatment Revenue Market Share by Countries (2014-2019)
Figure North America Chemotherapy-Induced Neutropenia Treatment Revenue Market Share by Countries in 2018
Figure USA Chemotherapy-Induced Neutropenia Treatment Revenue and Growth Rate (2014-2019)
Figure Canada Chemotherapy-Induced Neutropenia Treatment Revenue and Growth Rate (2014-2019)
Figure Mexico Chemotherapy-Induced Neutropenia Treatment Revenue and Growth Rate (2014-2019)
Table Europe Chemotherapy-Induced Neutropenia Treatment Revenue (Million USD) by Countries (2014-2019)
Figure Europe Chemotherapy-Induced Neutropenia Treatment Revenue Market Share by Countries (2014-2019)
Figure Europe Chemotherapy-Induced Neutropenia Treatment Revenue Market Share by Countries in 2018
Figure Germany Chemotherapy-Induced Neutropenia Treatment Revenue and Growth Rate (2014-2019)
Figure UK Chemotherapy-Induced Neutropenia Treatment Revenue and Growth Rate (2014-2019)
Figure France Chemotherapy-Induced Neutropenia Treatment Revenue and Growth Rate (2014-2019)
Figure Russia Chemotherapy-Induced Neutropenia Treatment Revenue and Growth Rate (2014-2019)
Figure Italy Chemotherapy-Induced Neutropenia Treatment Revenue and Growth Rate (2014-2019)
Table Asia-Pacific Chemotherapy-Induced Neutropenia Treatment Revenue (Million USD) by Countries (2014-2019)
Figure Asia-Pacific Chemotherapy-Induced Neutropenia Treatment Revenue Market Share by Countries (2014-2019)
Figure Asia-Pacific Chemotherapy-Induced Neutropenia Treatment Revenue Market Share by Countries in 2018
Figure China Chemotherapy-Induced Neutropenia Treatment Revenue and Growth Rate (2014-2019)
Figure Japan Chemotherapy-Induced Neutropenia Treatment Revenue and Growth Rate (2014-2019)
Figure Korea Chemotherapy-Induced Neutropenia Treatment Revenue and Growth Rate (2014-2019)
Figure India Chemotherapy-Induced Neutropenia Treatment Revenue and Growth Rate (2014-2019)
Figure Southeast Asia Chemotherapy-Induced Neutropenia Treatment Revenue and Growth Rate (2014-2019)
Table South America Chemotherapy-Induced Neutropenia Treatment Revenue by Countries (2014-2019)
Table South America Chemotherapy-Induced Neutropenia Treatment Revenue Market Share by Countries (2014-2019)
Figure South America Chemotherapy-Induced Neutropenia Treatment Revenue Market Share by Countries (2014-2019)
Figure South America Chemotherapy-Induced Neutropenia Treatment Revenue Market Share by Countries in 2018
Figure Brazil Chemotherapy-Induced Neutropenia Treatment Revenue and Growth Rate (2014-2019)
Figure Argentina Chemotherapy-Induced Neutropenia Treatment Revenue and Growth Rate (2014-2019)
Figure Colombia Chemotherapy-Induced Neutropenia Treatment Revenue and Growth Rate (2014-2019)
Table Middle East and Africa Chemotherapy-Induced Neutropenia Treatment Revenue (Million USD) by Countries (2014-2019)
Table Middle East and Africa Chemotherapy-Induced Neutropenia Treatment Revenue Market Share by Countries (2014-2019)
Figure Middle East and Africa Chemotherapy-Induced Neutropenia Treatment Revenue Market Share by Countries (2014-2019)
Figure Middle East and Africa Chemotherapy-Induced Neutropenia Treatment Revenue Market Share by Countries in 2018
Figure Saudi Arabia Chemotherapy-Induced Neutropenia Treatment Revenue and Growth Rate (2014-2019)
Figure UAE Chemotherapy-Induced Neutropenia Treatment Revenue and Growth Rate (2014-2019)
Figure Egypt Chemotherapy-Induced Neutropenia Treatment Revenue and Growth Rate (2014-2019)
Figure Nigeria Chemotherapy-Induced Neutropenia Treatment Revenue and Growth Rate (2014-2019)
Figure South Africa Chemotherapy-Induced Neutropenia Treatment Revenue and Growth Rate (2014-2019)
Table Global Chemotherapy-Induced Neutropenia Treatment Revenue (Million USD) by Type (2014-2019)
Table Global Chemotherapy-Induced Neutropenia Treatment Revenue Share by Type (2014-2019)
Figure Global Chemotherapy-Induced Neutropenia Treatment Revenue Share by Type (2014-2019)
Figure Global Chemotherapy-Induced Neutropenia Treatment Revenue Share by Type in 2019
Table Global Chemotherapy-Induced Neutropenia Treatment Revenue Forecast by Type (2019-2024)
Figure Global Chemotherapy-Induced Neutropenia Treatment Market Share Forecast by Type (2019-2024)
Figure Global Antibiotic Therapy Revenue Growth Rate (2014-2019)
Figure Global Colony-Stimulating Factor Therapy Revenue Growth Rate (2014-2019)
Figure Global Granulocyte Transfusion Revenue Growth Rate (2014-2019)
Figure Global Splenectomy Procedure Revenue Growth Rate (2014-2019)
Figure Global Others Revenue Growth Rate (2014-2019)
Table Global Chemotherapy-Induced Neutropenia Treatment Revenue by Application (2014-2019)
Table Global Chemotherapy-Induced Neutropenia Treatment Revenue Share by Application (2014-2019)
Figure Global Chemotherapy-Induced Neutropenia Treatment Revenue Share by Application (2014-2019)
Figure Global Chemotherapy-Induced Neutropenia Treatment Revenue Share by Application in 2019
Table Global Chemotherapy-Induced Neutropenia Treatment Revenue Forecast by Application (2019-2024)
Figure Global Chemotherapy-Induced Neutropenia Treatment Market Share Forecast by Application (2019-2024)
Figure Global Hospital Pharmacy Revenue Growth Rate (2014-2019)
Figure Global Retail Pharmacy Revenue Growth Rate (2014-2019)
Figure Global Online Pharmacy Revenue Growth Rate (2014-2019)
Figure Global Chemotherapy-Induced Neutropenia Treatment Revenue (Million USD) and Growth Rate Forecast (2019-2024)
Table Global Chemotherapy-Induced Neutropenia Treatment Revenue (Million USD) Forecast by Regions (2019-2024)
Figure Global Chemotherapy-Induced Neutropenia Treatment Revenue Market Share Forecast by Regions (2019-2024)
Figure North America Chemotherapy-Induced Neutropenia Treatment Revenue Market Forecast (2019-2024)
Figure Europe Chemotherapy-Induced Neutropenia Treatment Revenue Market Forecast (2019-2024)
Figure Asia-Pacific Chemotherapy-Induced Neutropenia Treatment Revenue Market Forecast (2019-2024)
Figure South America Chemotherapy-Induced Neutropenia Treatment Revenue Market Forecast (2019-2024)
Figure Middle East and Africa Chemotherapy-Induced Neutropenia Treatment Revenue Market Forecast (2019-2024)
化学療法誘発脱毛用頭皮クールデバイスの世界市場予測 2024年：メーカー別、地域別、種類・用途別（～2024） Scope of the Report: The worldwide market for Scalp Cool Devices for Chemotherapy Induced Hair Loss is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2024, from xx million US$ in 2019, according to a new GIR (Global Info Research) study. This report …- 世界のオピオイド誘発性便秘治療市場：市場規模・現状・予測 There are multiple drugs in the pipeline for opioid induced constipation treatment. Upon approval, these drugs will face little competition in this market which is largely untapped. There have not been many stable choices in the pharmaceutical industry for opioid induced constipation treatment over …
- 誘導多能性幹細胞市場：世界及び中国市場分析・予測（～2024年） Induced Pluripotent Stem Cells Market Insights 2019, Global and Chinese Scenario is a professional and in-depth study on the current state of the global Induced Pluripotent Stem Cells industry with a focus on the Chinese market. The report provides key statistics on the market status of the Induced …
- 世界の誘導多能性幹細胞市場：市場規模・現状・予測 Pluripotent stem cells are embryonic stem cells that have the potential to form all adult cell types and help in repairing of damaged tissues in the human body. An induced pluripotent stem cells, or iPSCs, are taken from any tissue (usually skin or blood) from a child or an adult and is genetically …
- 化学療法薬の世界市場予測 2024年：企業別、地域別、種類・用途別（～2024） Chemotherapy is the use of any drug to treat any disease. But to most people, the wordchemotherapy means drugs used for cancer treatment. Scope of the Report: The global Chemotherapy Drug market is valued at xx million USD in 2018 and is expected to reach xx million USD by the end of 2024, growing a…